In the US, Cefepime (cefepime systemic) is a member of the drug class fourth generation cephalosporins and is used to treat Bacteremia, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Nosocomial Pneumonia, Pneumonia, Skin and Structure Infection, Skin Infection and Urinary Tract Infection.
US matches:
- Cefepime
- Cefepime Injection
- Cefepime Hydrochloride
- Cefepime Hydrochloride and Dextrose
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J01DE01
CAS registry number (Chemical Abstracts Service)
0088040-23-7
Chemical Formula
C19-H24-N6-O5-S2
Molecular Weight
480
Therapeutic Category
Antibacterial: Cephalosporin
Chemical Name
1-[[(6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl-1-methylpyrrolidinium hydroxyde, inner salt, 7²-(Z)-(O-methyloxime)
Foreign Names
- Cefepimum (Latin)
- Cefepim (German)
- Cefepime (French)
- Cefepima (Spanish)
Generic Names
- Cefepime (OS: BAN, USAN)
- Céfépime (OS: DCF)
- BMY 28142 (IS: Bristol-Myers)
- CFPM (IS)
- Cefepime Hydrochloride (OS: BAN, USP, USAN)
- BMY 28142 2HCl.H20 (IS)
- Cefepime Hydrochloride Monohydrate (IS)
- Cefepime Dihydrochloride (PH: JP XIV)
- Cefepime Dihydrochloride Hydrate (PH: JP XV)
- Cefepime Dihydrochloride Monohydrate (PH: Ph. Eur. 6)
- Cefepime Hydrochloride (PH: USP 32)
- Cefepime Hydrochloride Monohydrate (PH: BP 2010)
- Cefepimi dihydrochloridum monohydricum (PH: Ph. Eur. 6)
Brand Names
- Aspime
Biogalenic, Venezuela - Cefepima
GP Pharm, Peru; Infarmasa, Peru - Cefepime
Apotex, Canada; APP, United States; Medigroup, Peru; Sagent Pharmaceuticals, United States; Vitalis, Peru - Ceficad
Cadila, India - Cefim
Hemofarm, Serbia - Cefimen-K
Klonal, Argentina - Cepime
Ranbaxy, Peru - Chase
Shreshtha, India - Exepime
Ferron, Indonesia - Fada Cefepime
Fada, Argentina - Forpar
Unifarma, Latvia - Gen 4
Ibn Sina, Bangladesh - Macef
Bernofarm, Indonesia - Maxicef
Galenika, Serbia - Maxilan
Landson, Indonesia - Maxipime
Bristol Meyers Squibb, Latvia; Bristol-Myers Squibb, Taiwan - Megapime
Exmek, Peru - Protec
Tabuk Pharmaceutical, Oman - Topra
GMP, Georgia - Vipime
Kalbe, Indonesia - Xenim
Opsonin, Bangladesh - Actacef
Actavis, Indonesia - Axépim
Bristol-Myers Squibb, Burkina Faso; Bristol-Myers Squibb, Burundi; Bristol-Myers Squibb, Benin; Bristol-Myers Squibb, Congo; Bristol-Myers Squibb, Cote D'ivoire; Bristol-Myers Squibb, Cameroon; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Gabon; Bristol-Myers Squibb, Guinea; Bristol-Myers Squibb, Mali; Bristol-Myers Squibb, Mauritius; Bristol-Myers Squibb, Niger; Bristol-Myers Squibb, Senegal; Bristol-Myers Squibb, Chad; Bristol-Myers Squibb, Togo; Bristol-Myers Squibb, Zaire - Cefdipime
Renata, Bangladesh - Cefepim Sandoz
Sandoz, Switzerland - Cefepima Libra
Libra, Vietnam - Cefepime Alvia
Alvia, Greece - Cefepime Genven
Genéricos Venezolanos, Venezuela - Céfépime Mylan
Mylan, France - Cefepime OrPha
OrPha, Switzerland - Cefepime Richet
Richet, Argentina - Cefepime
ACS Dobfar Generics, United States; Northia, Argentina; Orchid, United States - Ceforim
Sanbe, Indonesia - Cepim
Polifarma, Italy - Cepimax
Bristol-Myers Squibb, Philippines - Cepimex
Bruno, Italy - Efectus
Altian, Dominican Republic - Gazore
Alkem, Myanmar - Gencef
Genepharm, Greece - Interprim
Interbat, Indonesia - Maxcef
Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Israel - Maxef
Salus, Mexico - Maxicef
Pharos, Indonesia - Maxinject
Suan Farma S.A., Greece - Maxipime
Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Estonia; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, Georgia; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Malaysia; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Russian Federation; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Turkey; Bristol-Myers Squibb, Venezuela; Bristol-Myers Squibb, Vietnam; Bristol-Myers Squibb, South Africa; Elan, United States; Jadran, Bosnia & Herzegowina; Jadran, Croatia (Hrvatska); PharmaSwiss, Slovenia; Vianex / BIANEΞ, Greece - Procepim
Meprofarm, Indonesia - Rapime
Fahrenheit, Indonesia - Sandocef
Sandoz, Indonesia - Sopime
Soho, Indonesia - Ultrapime
Incepta, Bangladesh - Unisef
Mustafa Nevzat, Turkey
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| USP | Pharmacopoeia of the United States |
Click for further information on drug naming conventions and International Nonproprietary Names.
